Urology
Volume 72, Issue 1 , Pages 51-56 , July 2008

Malignant Extrinsic Ureteral Obstruction: A Survey of Urologists and Medical Oncologists Regarding Treatment Patterns and Preferences

  • Elias S. Hyams
    • ,
  • Ojas Shah

      Affiliations

    • Corresponding Author InformationReprint requests: Ojas Shah, M.D., Department of Urology, New York University School of Medicine, 150 E. 32nd Street, 2nd floor, New York, NY 10016.

Received 14 December 2007 ,Accepted 24 January 2008.

References 

  1. Ganatra AM, Loughlin KR. The management of malignant ureteral obstruction treated with ureteral stents. J Urol. 2005;174:2125–2128
  2. Ku JH, Lee SW, Jeon HG, et al. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?. Urology. 2004;64:895–899
  3. Wilson JR, Urwin GH, Stower MJ. The role of percutaneous nephrostomy in malignant ureteric obstruction. Ann R Coll Surg Engl. 2005;87:21–24
  4. Wong L, Cleeve LK, Milner AD, et al. Malignant ureteral obstruction: outcomes after intervention (Have things changed?). J Urol. 2007;178:178–183
  5. Park DS, Park JH, Lee YT. Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction. J Endourol. 2002;16:153–154
  6. Ekici S, Sahin A, Ozen H. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer. J Endourol. 2001;15:827–829
  7. Lau MW, Temperley DE, Mehta S, et al. Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Br J Urol. 1995;76:565–569
  8. Chung SY, Stein RJ, Landsittel D, et al. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol. 2004;172:592–595
  9. Liatsikos EN, Kagadis GC, Barbalias GA, et al. Ureteral metal stents: a tale or a tool?. J Endourol. 2005;19:934–939
  10. Barbalias GA, Siablis D, Liatsikos EN, et al. Metal stents: a new treatment of malignant ureteral obstruction. J Urol. 1997;158:54–58
  11. Tekin MI, Aytekin C, Aygun C, et al. Covered metallic ureteral stent in the management of malignant ureteral obstruction: preliminary results. Urology. 2001;58:919–923
  12. Beiko DT, Knudsen BE, Denstedt JD. Advances in ureteral stent design. J Endourol. 2003;17:195–199
  13. Liatsikos EN, Siablis D, Kalogeropoulou C, et al. Coated v noncoated ureteral metal stents: an experimental model. J Endourol. 2001;15:747–751
  14. Sur RL, Scales CD, Preminger GM, et al. Evidence-based medicine: a survey of American Urological Association members. J Urol. 2006;176:1127–1134

PII: S0090-4295(08)00126-X

doi: 10.1016/j.urology.2008.01.046

Urology
Volume 72, Issue 1 , Pages 51-56 , July 2008

Article Tools